| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
Mevalonic acid
Mevalonic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Mevalonic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Mevalonic acid
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with Mevalonic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lin YL et al. | Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. | 2003 | Virology | pmid:14517078 |
| Lyles DS et al. | An alteration in the kinetic properties of a cholesterogenic enzyme in fowlpox virus infection. | 1975 | Virology | pmid:237362 |
| Sidorkiewicz M et al. | Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cells. | 2009 | Virus Res. | pmid:19540284 |
| Targett-Adams P et al. | Lipid metabolism and HCV infection. | 2010 | Viruses | pmid:21994676 |
| Delang L et al. | Antiviral therapy for hepatitis C virus: beyond the standard of care. | 2010 | Viruses | pmid:21994657 |
| Rad SA et al. | Type 2 IDI performs better than type 1 for improving lycopene production in metabolically engineered E. coli strains. | 2012 | World J. Microbiol. Biotechnol. | pmid:22806807 |
| Akisato Y et al. | [Effect of pitavastatin on macrophage cholesterol metabolism]. | 2008 | Yakugaku Zasshi | pmid:18311054 |
| Iguchi K | [Effect of bisphosphonates on anticancer activity in prostate cancer cells]. | 2012 | Yakugaku Zasshi | pmid:23023419 |
| Tokoro T et al. | The novel HMG-CoA reductase inhibitor, Pitavastatin, induces a protective action in vascular endothelial cells through the production of nitric oxide (NO). | 2004 | Yakugaku Zasshi | pmid:15049129 |